Introduction
In 2010, 60 million American adults were diagnosed with hypertension (HTN), 1 and the National Heart, Lung, and Blood to be the most common cause of suboptimal response to antihypertensive therapy. 7 Compounding the issue is a low health literacy rate. According to the U.S. Department of Health and Human Services, over 77 million American adults have basic or below basic health literacy. 8 Low health literacy causes a great deal of miscommunication between healthcare professionals and their patients, and non-adherence leads to poor health outcomes and increased medical costs. 4 The primary care physician population in the U.S. is dwindling, and the number of medical students going into primary care has dropped by over 50% within the past decade. 9 An aging patient population coupled with declining numbers of primary care physicians may limit access to health care for many patients.
The accessibility of community pharmacists puts them in a unique position to help fill the gap in primary healthcare. According to the National Association of Chain Drug Stores, 92% of Americans live within five miles of a community pharmacy. 9 Additionally, the average patient who fills at least 6 prescriptions over a 12 month period, visits his/her pharmacy weekly compared with visiting his/her primary care physician every two and a half months. 9 Moreover, a 2013
Gallup poll cited pharmacists as the second most honest and ethical profession. 10 This level of trust and access places community pharmacists in a position to bridge the gap in care and provide quality, outcomes-based interventions to their patients.
The impact of community pharmacist interventions on health outcomes of HTN has been demonstrated as well. A systematic review and meta-analysis in pharmacists' HTN management reveals that medication management and education about HTN are the most common interventions.
11
Systolic blood pressure (SBP) was found "definitely-sensitive" to pharmacists' interventions, which suggests the impact of pharmacists' interventions on SBP are clinically important and statistically significant. Another systematic review and metaanalysis indicates education about HTN medications by nurses or pharmacists reduces blood pressure (BP). 12 
Objective
The objective of this study was to examine the effect of a medication synchronization program or an education program on hypertensive patients' health outcomes. These outcomes included SBP, diastolic blood pressure (DBP), proportion of patients at BP goal, change in self-rated medication adherence, and patients' knowledge of HTNrelated topics. The authors hypothesized education and medication synchronization interventions would produce significant SBP lowering compared to a control group.
Methods

Study Population and Study Design
The study took place at a family-owned, 15 store community pharmacy chain in northwest-central Missouri and was approved by the University of Missouri-Kansas City's Adult Health Sciences Institutional Review Board. Patients were enrolled at six retail locations and randomized by research staff into three groups based on enrollment order: control, medication synchronization, or education. Randomization occurred at the patient level, and within each pharmacy. Patients were given a number based on the order of enrollment and were not blinded to other groups. For example, the first person was assigned to group one (control), second to group two (medication synchronization), third to group three (education), fourth to group one (control), and so on. Study recruitment and follow-up lasted from January 2012-June 2012. Study locations were chosen based upon clinical staffing levels and availability to complete the study in the four-month time frame. The inclusion criteria were: 18 years of age or older, diagnosis of HTN inferred by medication use, prescribed at least one BP medication, and filled two or more prescriptions at the study site. Excluded patients were less than 18 years of age, had limitations to diet or exercise modification, experienced a heart attack or stroke within the six months prior to enrollment, had kidney failure or were on dialysis. Eligible patients received an invitation letter to participate and study participants received an automatic BP monitor for home use upon completing all visits as an incentive for participation. Control group patients did not receive additional intervention beyond monthly blood pressure checks assessed on a walk-in basis. Essentially this served as a feedback loop where control patients received feedback about their blood pressure. They were not reminded to come to the pharmacy to refill medications or to have their blood pressure measured. Medication synchronization group patients had all of their maintenance medication fills, including antihypertensive medication(s), synchronized to the one day each month that worked best for them to pick up all of their medications. This is referred to as the Appointment Based Model (ABM). 19 Prior to the appointment day, the patient was then called by a pharmacy staff member to determine if any medication changes occurred since the last month's appointment. This process reduced lapses in treatment by allowing the pharmacy staff to be proactive if a medication was in need of a refill or prior authorization. Additionally, refilling all medications on the same date allowed for monthly reviews of patients' complete current medications. The patient was then notified via phone call, or if preferred via text messaging, when all of the medications were ready to be picked up. BPs were measured for medication synchronization patients monthly upon picking up their medications. Education group patients received a monthly education session covering various topics related to HTN and improving hypertensive health outcomes, were given education materials to take home, and had their knowledge assessed at the visit. Education visits were conducted by a pharmacist and occurred concurrently with the BP measurement, on a walk-in basis. These patients were only asked to complete BP assessments if they were in the pharmacy filling prescriptions. They were not reminded to pick up prescriptions or to come to the pharmacy for BP visits. Education sessions were performed based upon a set of four patient handouts. Pharmacists provided an overview and discussion with each patient about the information contained within one handout during their monthly visit. The handout was then provided to the patient to take home and use as a reference. Handouts were presented within a 10-15 minute timeframe, and allowed comprehensive patient education without adversely affecting pharmacy workflow. Additionally, education patients completed a pre and posttest regarding the education topic to assess baseline knowledge and retention of information presented.
Study Interventions
Questions asked before and after education sessions were directly related to the monthly education topic presented. The same pharmacist did not perform every education session; however, one researcher trained all participating pharmacists to perform the sessions. The standardized training provided consistency to the education sessions. The handouts were presented in the following order: the basics of BP, lifestyle modification through diet, lifestyle modification through exercise, and the importance of medication adherence. All handout information was derived from the American Heart Association (AHA) and the JNC-7 hypertension guidelines. 18, 20 Each topic was written at a fifth grade reading level, and printed in color.
For all study groups, patients' self-reported adherence to medication regimens was measured via the Morisky, Green, and Levine (MGL) Adherence Scale. 21 The MGL is a series of four yes/no questions, scored zero through four, which were incorporated into the baseline and final questionnaires. If patients answered "yes" to any question, they were more likely to be non-adherent. 21 Adherence was measured by a self-rated scale alone because measuring prescription refill history would show perfect adherence within the medication synchronization group due to the nature of the intervention.
Patients' knowledge of topics related to HTN was assessed in the baseline and final questionnaire with a series of five questions related to BP goals, influence of diet and exercise on BP, complications of uncontrolled HTN, and identification of BP medications. The knowledge questions were derived from the AHA website, and correspond with questions asked on pre/post-tests administered during education visits. 20 All education topics and HTN knowledge pre/post-tests were reviewed by clinical staff, non-clinical staff, and lay people for clarity and relevance prior to administration to patients. 
Results
Enrollment letters were sent to 6,397 patients and 302 enrolled to participate in the study. Three hundred and two patients were randomized into the three study groups: control, medication synchronization, and education. At the conclusion of the study, 94, 95, and 86 patients in the control group, medication synchronization group, and education group, respectively, completed all study activities. Nine, seven and eleven patients were lost to follow-up in the control, medication synchronization, and education groups respectively. Reasons for loss at follow-up included: patients not willing to complete interventions, patients consistently not showing for visits, and patients entering long term care facilities. Baseline characteristics of study patients are displayed in Table 1 . All baseline characteristics were similar among groups. Patients were generally female, 65 years of age, taking at least two BP medications, and had a high school education or above. Of the total study population, 41% were male and 27% were diabetic.
All groups had a significant SBP decline (p<0.05) from baseline, however there were no significant monthly SBP differences among study groups (Table 2) . Also, the control group produced significant DBP (p=0.002) decreases from baseline, but there were no significant differences among study groups at final BP analysis. For the control group and education group, the proportion of patients achieving BP goals increased at Month 4 (Table 3) . From the baseline/final questionnaire, there were no significant changes in subject perception of adherence before and after the intervention for any study group (Table 4) . The most commonly reported reason for non-adherence was forgetfulness with 50.6% of patients reporting this reason. Control group patients had a positive change on 20% of HTN knowledge questions, while medication synchronization group patients had a positive change on 40%. The education group improved scores on 60% of HTN knowledge questions. Notably, the education group experienced a 27.1% increase in correct identification of appropriate amount of exercise needed for BP lowering (p<0.001).
Discussion
Our study evaluated the effect of community pharmacist intervention on SBP and DBP among groups and from baseline, proportion of patients achieving BP goal, and patient perception of medication adherence. In this study all groups produced significant SBP lowering from baseline, however there were no significant SBP differences among study groups. A significant SBP difference between groups may have been seen if only patients with uncontrolled HTN were enrolled in the study. At baseline each study group started out with a substantial proportion of patients already meeting treatment goals: control 49.0%, medication synchronization 41.8%, and education 38.3%. This may have reduced the ability to see improvements across all groups. Had only patients with uncontrolled hypertension been enrolled there would have been more room for impact. However, we felt enabling all patients, even those at goal, to take charge of their health through lifestyle was a worthy cause and reason to include these patients, if interested in participation. 
Control group patients had their
INNOVATIONS in pharmacy
The absence of change in self-reported adherence scores within study groups suggests it is difficult to change patient adherence by the singular act of synchronizing medications and reminding the patient to pick them up when they are due. There is a need for interventions that focus on motivation and awareness of the importance of taking medication as prescribed in addition to ensuring the patient physically has the medication. With forgetfulness being the most commonly reported reason for non-adherence in this study, it is important for community pharmacists to communicate with patients about barriers to adherence. The proactive nature of the medication synchronization program allows the pharmacy staff to prepare for patient consultations regarding adherence or other underlying health or medication-related issues by knowing when to expect these patients at the pharmacy using the ABM. While providing education on medication regimens, community pharmacists can impact adherence by suggesting additional tools, such as medication planners and alarms, to remind patients to take their medications. Given the need to follow the research protocol and measure BP at pick up times, adherence was not directly discussed with medication synchronization patients; it was only evaluated through the study questionnaire.
Based on answers to HTN knowledge questions, patients in the education group improved on questions regarding the amount of exercise needed to impact BP lowering. Awareness of the appropriate amount of exercise may influence patients to exercise more, and consequently decrease BP. Exercise is an important component to attaining BP control. Within the education group, 60% of knowledge questions on pre/post-tests demonstrated an increase in proportion of patients answering the question correctly after the intervention. This indicates that the educational materials presented to patients may have successfully informed them on various HTN topics.
Limitations
The short four-month duration was a limitation of this study. A longer time period may be necessary to detect significant SBP differences between intervention groups at final analysis. There may have been selection bias in the study where the people who volunteered are likely different from those who did not. This may explain why medication synchronization did not have an impact on BP reduction. The control group may have also experienced compensatory rivalry. Upon knowing the other two groups were receiving an additional intervention, they may have decided to seek out additional intervention on their own or modify their own medicationtaking behaviors. Another limitation was subject behavioral factors that could cause elevated blood pressure were not assessed. These factors might include exercise, caffeine intake, stress, and/or nicotine intake within 30 minutes prior to BP measurement. Additionally, although the pharmacists performing the interventions were trained prior to enrollment by a sole researcher, they were not monitored throughout the study to ensure the integrity of design was maintained.
For a self-reported adherence measure, such as the MGL, patients may be more likely to respond with what the health provider would like to hear versus how they actually use medications. Although, completing a paper survey may allow the patient to answer more freely than when answered face to face. Despite limitations, steps were taken to minimize the amount of bias and incidence of error. This included randomization, offering enrollment to all HTN patients at the pharmacy, and estimating sample size based on sufficient power.
Trending results including decreased blood pressure and changes in knowledge are promising, and future studies of longer duration and modified study logistics need to be conducted to examine differences among study groups. Based on the results of this study, a hypertension monitoring fee-for-service program was implemented in all pharmacies within the organization. Additionally, it was determined that the medication synchronization program needed enhancement to include a patient consultation each month when medications were picked up to assess adherence, changes in regimen, or any additional questions or concerns.
Conclusion
All groups had significant SBP lowering from baseline to Month 4, however there were no significant SBP differences among study groups. Medication synchronization did not lead to a significant increase in proportion of patients at BP goal. This may indicate that further intervention is needed to impact adherence aside from ensuring that patients have their medication on hand. There were no significant changes in self-reported medication adherence in any study groups, but the education group reported positive change with being more careful about taking medications and with not forgetting to take medications when they felt better. This study also demonstrated that educational materials written at an appropriate level and presented by community pharmacists to patients may have been associated with an increase in HTN knowledge and a significant increase in the proportion of patients achieving their BP goal. 
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